30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

2Q13 Revenue: Symmetry Medical

$101.9MM, flat

  • Instruments $28.1MM, -1%
  • Implants $28.1MM, +12%
  • Cases $17.1MM, +18%
  • Other $6.3MM, -9%
  • Surgical $22.3MM, -18%


  • Results reflect stabilizing orthopaedic procedure environment
  • Implants benefited from consumption demand, timing of stocking orders, customer inventory adjustments
  • Anticipated OEM supplier rationalization opportunities not occurring as rapidly as expected; sluggishness may derive from amount of resources required to transfer work from one supplier to another